Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 5/2012

Open Access 01-05-2012 | Article

Initial microbial spectrum in severe secondary peritonitis and relevance for treatment

Authors: O. van Ruler, J. J. S. Kiewiet, R. J. van Ketel, M. A. Boermeester, On behalf of the Dutch Peritonitis Study Group

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 5/2012

Login to get access

Abstract

This study aims to determine whether abdominal microbial profiles in early severe secondary peritonitis are associated with ongoing infection or death. The study is performed within a randomized study comparing two surgical treatment strategies in patients with severe secondary peritonitis (n = 229). The microbial profiles of cultures retrieved from initial emergency laparotomy were tested with logistic regression analysis for association with ‘ongoing infection needing relaparotomy’ and in-hospital death. No microbial profile or the presence of yeast or Pseudomonas spp. was related to the risk of ongoing infection needing relaparotomy. Resistance to empiric therapy for gram positive cocci and coliforms was moderately associated with ongoing abdominal infection (OR 3.43 95%CI 0.95–12.38 and OR 7.61, 95%CI 0.75–76.94). Presence of only gram positive cocci, predominantly Enterococcus spp, was borderline independently associated with in-hospital death (OR 3.69, 95%CI 0.99–13.80). In secondary peritonitis microbial profiles do not predict ongoing abdominal infection after initial emergency laparotomy. However, the moderate association of ongoing infection with resistance to the empiric therapy compels to more attention for resistance when selecting empiric antibiotic coverage.
Literature
1.
go back to reference Lamme B, Mahler CW, van Till JW, van Ruler O, Gouma DJ, Boermeester MA (2005) Relaparotomy in secondary peritonitis. Planned relaparotomy or relaparotomy on demand? Chirurg 76:856–867PubMedCrossRef Lamme B, Mahler CW, van Till JW, van Ruler O, Gouma DJ, Boermeester MA (2005) Relaparotomy in secondary peritonitis. Planned relaparotomy or relaparotomy on demand? Chirurg 76:856–867PubMedCrossRef
2.
go back to reference Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873PubMedCrossRef Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873PubMedCrossRef
3.
go back to reference Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146–155PubMedCrossRef Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146–155PubMedCrossRef
4.
go back to reference Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462–474PubMedCrossRef Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462–474PubMedCrossRef
5.
go back to reference Anaya DA, Nathens AB (2003) Risk factors for severe sepsis in secondary peritonitis. Surg Infect (Larchmt) 4:355–362CrossRef Anaya DA, Nathens AB (2003) Risk factors for severe sepsis in secondary peritonitis. Surg Infect (Larchmt) 4:355–362CrossRef
6.
go back to reference Bohnen J, Boulanger M, Meakins JL, McLean AP (1983) Prognosis in generalized peritonitis. Relation to cause and risk factors. Arch Surg 118:285–290PubMedCrossRef Bohnen J, Boulanger M, Meakins JL, McLean AP (1983) Prognosis in generalized peritonitis. Relation to cause and risk factors. Arch Surg 118:285–290PubMedCrossRef
7.
go back to reference Fry DE, Garrison RN, Heitsch RC, Calhoun K, Polk HC Jr (1980) Determinants of death in patients with intraabdominal abscess. Surgery 88:517–523PubMed Fry DE, Garrison RN, Heitsch RC, Calhoun K, Polk HC Jr (1980) Determinants of death in patients with intraabdominal abscess. Surgery 88:517–523PubMed
8.
go back to reference Grunau G, Heemken R, Hau T (1996) Predictors of outcome in patients with postoperative intra-abdominal infection. Eur J Surg 162:619–625PubMed Grunau G, Heemken R, Hau T (1996) Predictors of outcome in patients with postoperative intra-abdominal infection. Eur J Surg 162:619–625PubMed
9.
go back to reference Holzheimer RG, Gathof B (2003) Re-operation for complicated secondary peritonitis—how to identify patients at risk for persistent sepsis. Eur J Med Res 8:125–134PubMed Holzheimer RG, Gathof B (2003) Re-operation for complicated secondary peritonitis—how to identify patients at risk for persistent sepsis. Eur J Med Res 8:125–134PubMed
10.
go back to reference Lamme B, Mahler CW, van Ruler O, Gouma DJ, Reitsma JB, Boermeester MA (2006) Clinical predictors of ongoing infection in secondary peritonitis: systematic review. World J Surg 30:2170–2181 Lamme B, Mahler CW, van Ruler O, Gouma DJ, Reitsma JB, Boermeester MA (2006) Clinical predictors of ongoing infection in secondary peritonitis: systematic review. World J Surg 30:2170–2181
11.
go back to reference Pusajo JF, Bumaschny E, Doglio GR, Cherjovsky MR, Lipinszki AI, Hernandez MS, Egurrola MA (1993) Postoperative intra-abdominal sepsis requiring reoperation. Value of a predictive index. Arch Surg 128:218–222PubMedCrossRef Pusajo JF, Bumaschny E, Doglio GR, Cherjovsky MR, Lipinszki AI, Hernandez MS, Egurrola MA (1993) Postoperative intra-abdominal sepsis requiring reoperation. Value of a predictive index. Arch Surg 128:218–222PubMedCrossRef
12.
go back to reference van Ruler O, Mahler CW, Boer KR, Reuland EA, Gooszen HG, Opmeer BC, de Graaf PW, Lamme B, Gerhards MF, Steller EP, van Till JW, de Borgie CJ, Gouma DJ, Reitsma JB, Boermeester MA, Dutch Peritonitis Study Group (2007) Comparison of on-demand versus planned relaparotomy strategy in patients with severe peritonitis. A randomized trial. JAMA 298(8):865–872 van Ruler O, Mahler CW, Boer KR, Reuland EA, Gooszen HG, Opmeer BC, de Graaf PW, Lamme B, Gerhards MF, Steller EP, van Till JW, de Borgie CJ, Gouma DJ, Reitsma JB, Boermeester MA, Dutch Peritonitis Study Group (2007) Comparison of on-demand versus planned relaparotomy strategy in patients with severe peritonitis. A randomized trial. JAMA 298(8):865–872
13.
go back to reference van Goor H (2002) Interventional management of abdominal sepsis: when and how. Langenbecks Arch Surg 387:191–200PubMedCrossRef van Goor H (2002) Interventional management of abdominal sepsis: when and how. Langenbecks Arch Surg 387:191–200PubMedCrossRef
14.
go back to reference van Ruler O, Lamme B, Gouma DJ, Reitsma JB, Boermeester MA (2007) Variables associated with positive findings at relaparotomy in patients with secondary peritonitis. Crit Care Med 35:468–476PubMedCrossRef van Ruler O, Lamme B, Gouma DJ, Reitsma JB, Boermeester MA (2007) Variables associated with positive findings at relaparotomy in patients with secondary peritonitis. Crit Care Med 35:468–476PubMedCrossRef
15.
go back to reference Wacha H, Hau T, Dittmer R, Ohmann C (1999) Risk factors associated with intraabdominal infections: a prospective multicenter study. Peritonitis Study Group. Langenbecks Arch Surg 384:24–32PubMedCrossRef Wacha H, Hau T, Dittmer R, Ohmann C (1999) Risk factors associated with intraabdominal infections: a prospective multicenter study. Peritonitis Study Group. Langenbecks Arch Surg 384:24–32PubMedCrossRef
16.
go back to reference Wacha H, Linder MM, Feldmann U, Wesch G, Gundlach E, Steifensand RA (1987) Mannheim Peritonitis Index—prediction of risk of death from peritonitis: construction of a statistical and validation of an emperically based index. Theor Surg 169–177 Wacha H, Linder MM, Feldmann U, Wesch G, Gundlach E, Steifensand RA (1987) Mannheim Peritonitis Index—prediction of risk of death from peritonitis: construction of a statistical and validation of an emperically based index. Theor Surg 169–177
17.
go back to reference Wittmann DH, Muller M (1987) Patient stratification in intra-abdominal infection. Chemioterapia 6:460–462PubMed Wittmann DH, Muller M (1987) Patient stratification in intra-abdominal infection. Chemioterapia 6:460–462PubMed
18.
go back to reference Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, Buchman T, Dellinger EP, Jernigan J, Gorbach S, Chow AW, Bartlett J (2003) Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 37:997–1005PubMedCrossRef Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, Buchman T, Dellinger EP, Jernigan J, Gorbach S, Chow AW, Bartlett J (2003) Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 37:997–1005PubMedCrossRef
19.
go back to reference Wong PF, Gilliam AD, Kumar S, Shenfine J, O'Dair GN, Leaper DJ (2005) Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. Cochrane Database Syst Rev CD004539 Wong PF, Gilliam AD, Kumar S, Shenfine J, O'Dair GN, Leaper DJ (2005) Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. Cochrane Database Syst Rev CD004539
20.
go back to reference Barie PS, Hydo LJ, Shou J, Larone DH, Eachempati SR (2005) Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection. Surg Infect (Larchmt) 6:41–54CrossRef Barie PS, Hydo LJ, Shou J, Larone DH, Eachempati SR (2005) Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection. Surg Infect (Larchmt) 6:41–54CrossRef
21.
go back to reference Barie PS, Christou NV, Dellinger EP, Rout WR, Stone HH, Waymack JP (1990) Pathogenicity of the enterococcus in surgical infections. Ann Surg 212:155–159PubMedCrossRef Barie PS, Christou NV, Dellinger EP, Rout WR, Stone HH, Waymack JP (1990) Pathogenicity of the enterococcus in surgical infections. Ann Surg 212:155–159PubMedCrossRef
22.
go back to reference Chatterjee I, Iredell JR, Woods M, Lipman J (2007) The implications of enterococci for the intensive care unit. Crit Care Resusc 9:69–75PubMed Chatterjee I, Iredell JR, Woods M, Lipman J (2007) The implications of enterococci for the intensive care unit. Crit Care Resusc 9:69–75PubMed
23.
go back to reference Christou NV, Turgeon P, Wassef R, Rotstein O, Bohnen J, Potvin M (1996) Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intra-abdominal Infection Study Group. Arch Surg 131:1193–1201PubMedCrossRef Christou NV, Turgeon P, Wassef R, Rotstein O, Bohnen J, Potvin M (1996) Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intra-abdominal Infection Study Group. Arch Surg 131:1193–1201PubMedCrossRef
24.
go back to reference Garbino J, Villiger P, Caviezel A, Matulionyte R, Uckay I, Morel P, Lew D (2007) A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections. Infection 35:161–166PubMedCrossRef Garbino J, Villiger P, Caviezel A, Matulionyte R, Uckay I, Morel P, Lew D (2007) A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections. Infection 35:161–166PubMedCrossRef
25.
go back to reference Harbarth S, Uckay I (2004) Are there patients with peritonitis who require empiric therapy for enterococcus? Eur J Clin Microbiol Infect Dis 23:73–77PubMedCrossRef Harbarth S, Uckay I (2004) Are there patients with peritonitis who require empiric therapy for enterococcus? Eur J Clin Microbiol Infect Dis 23:73–77PubMedCrossRef
26.
go back to reference Krobot K, Yin D, Zhang Q, Sen S, Altendorf-Hofmann A, Scheele J, Sendt W (2004) Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 23(9):682–687 Krobot K, Yin D, Zhang Q, Sen S, Altendorf-Hofmann A, Scheele J, Sendt W (2004) Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 23(9):682–687
27.
go back to reference Solomkin JS, Wilson SE, Christou NV, Rotstein OD, Dellinger EP, Bennion RS, Pak R, Tack K (2001) Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections. Ann Surg 233:79–87PubMedCrossRef Solomkin JS, Wilson SE, Christou NV, Rotstein OD, Dellinger EP, Bennion RS, Pak R, Tack K (2001) Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections. Ann Surg 233:79–87PubMedCrossRef
28.
go back to reference Top J, Willems R, Blok H, de Regt M, Jalink K, Troelstra A, Goorhuis B, Bonten M (2007) Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clin Microbiol Infect 13:316–319PubMedCrossRef Top J, Willems R, Blok H, de Regt M, Jalink K, Troelstra A, Goorhuis B, Bonten M (2007) Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clin Microbiol Infect 13:316–319PubMedCrossRef
29.
go back to reference Wacha H, Warren B, Bassaris H, Nikolaidis P (2006) Comparison of sequential intravenous/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections Surg. Infect (Larchmt) 7:341–354CrossRef Wacha H, Warren B, Bassaris H, Nikolaidis P (2006) Comparison of sequential intravenous/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections Surg. Infect (Larchmt) 7:341–354CrossRef
30.
go back to reference Nethmap (2009) Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. Available at www.swab.nl. Accessed 05 January 2011 Nethmap (2009) Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. Available at www.​swab.​nl. Accessed 05 January 2011
31.
go back to reference van Till JWO, van Ruler O, Lamme B, Weber RJP, Reitsma JB, Boermeester MA (2007) Single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients: a systematic review. Crit Care 11 van Till JWO, van Ruler O, Lamme B, Weber RJP, Reitsma JB, Boermeester MA (2007) Single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients: a systematic review. Crit Care 11
32.
go back to reference Driscoll JA, Brody SL, Kollef MH (2007) The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67:351–368PubMedCrossRef Driscoll JA, Brody SL, Kollef MH (2007) The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67:351–368PubMedCrossRef
33.
go back to reference Herold CJ, Sailer JG (2004) Community-acquired and nosocomial pneumonia. Eur Radiol 14(Suppl 3):E2–E20PubMed Herold CJ, Sailer JG (2004) Community-acquired and nosocomial pneumonia. Eur Radiol 14(Suppl 3):E2–E20PubMed
Metadata
Title
Initial microbial spectrum in severe secondary peritonitis and relevance for treatment
Authors
O. van Ruler
J. J. S. Kiewiet
R. J. van Ketel
M. A. Boermeester
On behalf of the Dutch Peritonitis Study Group
Publication date
01-05-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 5/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1357-0

Other articles of this Issue 5/2012

European Journal of Clinical Microbiology & Infectious Diseases 5/2012 Go to the issue